The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples